I’m finding it hard to see a way out for Biotron now, they will get the R&D rebate and pay off the loan but that will leave them only enough money for wages, more worrying for them is that they have captured the attention of the ASX and were found slack in their announcements to the market, quite a serious blunder. They also don’t appear to have a realistic plan for future trials.
I’m finding it hard to see a way out for Biotron now, they will...
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $5.764K | 303.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1202498 | 5 |
View Market Depth
| Last trade - 10.49am 27/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |